FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Kilitch Drugs (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524500 NSE Symbol: KILITCH P/E (TTM) :23.09
ISIN Demat:INE729D01010 Div & Yield %:0 EPS (TTM) :19.37
Book Value (RS) :157.2797549 Market Cap (Rs Cr.):719.2 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Mar 2025)		 Quarter Ended
(Mar 2024)		 Quarter Ended
(% Var)
Sales 56.30 39.14 43.84
Other Income 2.32 0.90 157.78
PBIDT 16.23 6.11 165.63
Interest 0.72 0.44 63.64
PBDT 15.51 5.67 173.54
Depreciation 0.51 0.41 24.39
PBT 15.00 5.26 185.17
Tax 3.56 1.32 169.70
Deferred Tax 0.07 0.30 -76.67
PAT 11.37 3.64 212.36

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)